anti-MAPKAP Kinase 5 (MAPKAPK5) Antikörper

Bezeichnung:
anti-Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 Antikörper (MAPKAPK5)
Auf www.antikoerper-online.de finden Sie aktuell 176 Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5) Antikörper von 18 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen MAPKAP Kinase 5 Proteine (12) und MAPKAP Kinase 5 Kits (5) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 208 MAPKAP Kinase 5 Produkte verfügbar.
Synonyme:
MAPKAP-K5, MAPKAPK5, MK-5, MK5, PRAK
Alle Antikörper anzeigen Gen GeneID UniProt
MAPKAPK5 17165 O54992
MAPKAPK5 8550 Q8IW41
MAPKAPK5 498183  

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-MAPKAP Kinase 5 (MAPKAPK5) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Mouse (Murine) MAPKAP Kinase 5 Antikörper:

anti-Human MAPKAP Kinase 5 Antikörper:

anti-Rat (Rattus) MAPKAP Kinase 5 Antikörper:

Alle verfügbaren anti-MAPKAP Kinase 5 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-MAPKAP Kinase 5 Antikörper

  1. Human Monoclonal MAPKAP Kinase 5 Primary Antibody für IHC, ELISA - ABIN969362 : Paliga, Natale, Watson: p38 mitogen-activated protein kinase (MAPK) first regulates filamentous actin at the 8-16-cell stage during preimplantation development. in Biology of the cell / under the auspices of the European Cell Biology Organization 2005 (PubMed)
    Zeige alle 3 Referenzen für 969362

  2. Human Polyclonal MAPKAP Kinase 5 Primary Antibody für EIA, WB - ABIN359410 : Sudo, Maruyama, Osada: p62 functions as a p38 MAP kinase regulator. in Biochemical and biophysical research communications 2000 (PubMed)
    Zeige alle 3 Referenzen für 359410

  3. Human Polyclonal MAPKAP Kinase 5 Primary Antibody für EIA, IHC (p) - ABIN358154 : New, Jiang, Zhao, Liu, Zhu, Flood, Kato, Parry, Han: PRAK, a novel protein kinase regulated by the p38 MAP kinase. in The EMBO journal 1998 (PubMed)
    Zeige alle 2 Referenzen für 358154

  4. Human Polyclonal MAPKAP Kinase 5 Primary Antibody für ICC, IF - ABIN4347179 : Stadler, Rexhepaj, Singan, Murphy, Pepperkok, Uhlén, Simpson, Lundberg: Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. in Nature methods 2013 (PubMed)

  5. Human Polyclonal MAPKAP Kinase 5 Primary Antibody für IHC (p), WB - ABIN389587 : Daily, Monks, Leggas, Moscow: Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibition. in Toxicon : official journal of the International Society on Toxinology 2010 (PubMed)

Weitere Antikörper gegen MAPKAP Kinase 5 Interaktionspartner

Mouse (Murine) Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5) Interaktionspartner

  1. MK5 haplodeficiency attenuated the progression of hypertrophy, reduced collagen type 1 mRNA, and protected diastolic function in response to chronic pressure overload.

  2. An alternative targeting strategy of MK5/PRAK (termed MK5/PRAK-Deltaex6) increased neither tumor incidence in the one step skin carcinogenesis model, nor Ras-induced transformation in primary cells.

  3. MK5 positively regulates Rag transcription via phosphorylation of Foxo1 (zeige FOXO1 Antikörper) in developing B cells.

  4. observations have demonstrated that PRAK is not required for either the rottlerin-mediated anti-chlamydial activity or rottlerin inhibition of sphingolipid trafficking, suggesting rottlerin may achieve its inhibitory role by targeting other host factors

  5. Results suggest that PRAK may function as a tumor suppressor in multiple types of cancers.

  6. the regulation of neuronal morphogenesis is proposed as the first physiological function of the ERK3 (zeige RYK Antikörper)/MK5 signaling module

  7. It was shown that the tumor-suppressing and tumor-promoting functions of the p38 (zeige CRK Antikörper)-PRAK pathway are temporally and spatially separated during cancer development in vivo, relying on the stimulus, and the tissue type and the stage of cancer development.

  8. Rheb (zeige RHEB Antikörper) inactivation by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1

  9. MK5 co-immunoprecipitated ERK3 (zeige RYK Antikörper), but not ERK4 (zeige MAPK4 Antikörper) or p38 alpha (zeige MAPK14 Antikörper), in control and hypertrophying hearts (MK5).

  10. Both binding and activation of p38 mitogen-activated protein kinase (zeige MAPK14 Antikörper) (MAPK (zeige MAPK1 Antikörper)) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress.

Human Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5) Interaktionspartner

  1. PRAK might be a potential therapeutic target of Alzheimer's disease involved in receptor for advanced glycation end products-mediated cell signaling induced by Abeta (zeige APP Antikörper)

  2. Plasma MAPKAPK5 protein was found to positively associate with the 10-year change in paired associates learning assessment in asymptomatic older twins.

  3. Data highlight that DJ-1 (zeige PARK7 Antikörper) is the downstream interacting target for PRAK, and in response to oxidative stress PRAK may exert a cytoprotective effect by facilitating DJ-1 (zeige PARK7 Antikörper) to sequester Daxx (zeige DAXX Antikörper) in the nucleus, thus preventing cell death.

  4. Data indicate that the structurally most flexible regions during molecular dynamics (MD) simulations of the native mitogen-activated protein kinase (zeige MAPK1 Antikörper)-activated protein kinase (zeige CDK7 Antikörper) MK5 model were the loop regions.

  5. Studies with specific phosphoantibodies indicate that MK5 phosphorylates Hsp40/DnaJB1 (zeige DNAJB1 Antikörper) in vivo at Ser (zeige SIGLEC1 Antikörper)-149 or/and Ser (zeige SIGLEC1 Antikörper)-151 and Ser (zeige SIGLEC1 Antikörper)-171 in the C-terminal domain of Hsp40/DnaJB1 (zeige DNAJB1 Antikörper).

  6. study shows Tip60 (zeige KAT5 Antikörper) plays an essential role in oncogenic ras-induced senescence; revealed a cascade of posttranslational modifications involving p38 (zeige CRK Antikörper), Tip60 (zeige KAT5 Antikörper) and PRAK, 3 proteins essential for ras-induced senescence; these modifications are critical for prosenescent function of Tip60 (zeige KAT5 Antikörper) and PRAK

  7. these results firstly demonstrate that MK5 is degraded in response to doxorubicin and negatively regulates doxorubicin-induced apoptosis, providing novel insights into the molecular mechanism of doxorubicin resistance in hepatoma cells.

  8. IGF2BP1 (zeige IGF2BP1 Antikörper) promotes the velocity and directionality of tumor-derived cell migration by determining the cytoplasmic fate of two novel target mRNAs: MAPK4 (zeige MAPK4 Antikörper) and PTEN (zeige PTEN Antikörper)

  9. Rheb (zeige RHEB Antikörper) inactivation by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1

  10. Activation loop phosphorylation of ERK3/ERK4 (zeige MAPK4 Antikörper) by group I p21 (zeige CDKN1A Antikörper)-activated kinases (PAKs) defines a novel PAK-ERK3 (zeige MAPK4 Antikörper)/4-MAPK-activated protein kinase 5 signaling pathway.

MAPKAP Kinase 5 (MAPKAPK5) Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a tumor suppressor and member of the serine/threonine kinase family. In response to cellular stress and proinflammatory cytokines, this kinase is activated through its phosphorylation by MAP kinases including MAPK1/ERK, MAPK14/p38-alpha, and MAPK11/p38-beta. The encoded protein is found in the nucleus but translocates to the cytoplasm upon phosphorylation and activation. This kinase phosphorylates heat shock protein HSP27 at its physiologically relevant sites. Two alternately spliced transcript variants of this gene encoding distinct isoforms have been reported.

Alternative names and synonyms associated with MAPKAP Kinase 5 (MAPKAPK5)

  • mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5) Antikörper
  • mitogen-activated protein kinase-activated protein kinase 5 (mapkapk5) Antikörper
  • MAP kinase-activated protein kinase 5 (Mapkapk5) Antikörper
  • mitogen-activated protein kinase-activated protein kinase 5 (Mapkapk5) Antikörper
  • MAPKAP-K5 Antikörper
  • MAPKAPK5 Antikörper
  • MK-5 Antikörper
  • MK5 Antikörper
  • PRAK Antikörper

Bezeichner auf Proteinebene für MAPKAPK5

mitogen-activated protein kinase-activated protein kinase 5 , MAP kinase-activated protein kinase 5 , MAP kinase-activated protein kinase 5-like , MAPK-activated protein kinase 5 , MAPKAP kinase 5 , MAPKAPK-5 , p38-regulated/activated protein kinase

GENE ID SPEZIES
100057579 Equus caballus
738233 Pan troglodytes
100017664 Monodelphis domestica
100230432 Taeniopygia guttata
100412389 Callithrix jacchus
100434701 Pongo abelii
100482977 Ailuropoda melanoleuca
100548508 Meleagris gallopavo
100553264 Anolis carolinensis
100582875 Nomascus leucogenys
17165 Mus musculus
8550 Homo sapiens
498183 Rattus norvegicus
373929 Gallus gallus
477480 Canis lupus familiaris
100153404 Sus scrofa
535625 Bos taurus
Ausgewählte Anbieter für anti-MAPKAP Kinase 5 (MAPKAPK5) Antikörper
Haben Sie etwas anderes gesucht?